Conference Agenda

2019 BFC Global Healthcare BD & Investment ConferenceDownload

Sunday, January 6, 2019

  • TIME
  • 8:00 – 9:00
  • 9:00 – 9:15
    Opening Remarks

    Speaker: David Chen, Managing Director, BFC Group
  • Session 1:
    Asymchem Global Pharma &Biotech Symposium
  • 9:15 – 10:15
    Cross-border licensing deal trend – Perspective from leading biopharma players

    Moderator:Christina Zhang, Partner-in-Charge of Shanghai Office, Cooley LLP
    Glenn P. Sblendorio, M.B.A., President and Chief Executive Officer, Ophthotech Corporation
    Lila Hope, Partner in Global Life Sciences Partnering and Licensing Group, Cooley LLP
    Samuel Murphy, VP and Head of International Business Development, Salubris Pharmaceuticals
    Gayatri Varma, Director, Partnering & Strategy at MedImmune The Early Stage Biologics R&D Unit, AstraZeneca
    Astrid Maria Dahl, Ph.D., MBA, Executive Business Development Director - Oncology, AstraZeneca
  • 10:15 – 11:15
    IPO market in US and Hong Kong – Getting the best of both markets

    Moderator:Charlie Kim, Partner and Co-Head of Global Capital Markets Group at Cooley
    David Ke, Executive Director, J.P. Morgan Investment Bank, Healthcare Equity Capital Markets
    Lili Zheng, Managing Partner, Deloitte
    David Lau, Managing Director and Head of Investment Banking, J.P. Morgan Hong Kong
    Y. Katherine Xu, Partner and Co-Head of the Biopharmaceutical Equity Research Group, William Blair
    Jonie Kondracki, Partner in Global Capital Markets Group, Cooley LLP
  • 11:15 – 11:45
    Tea Break
  • 11:45 – 12:45
    Access to China: Market, Regulation, Science, Investment and Solutions

    Moderator:Dr. James Gage, Chief Scientific Officer of Asymchem
    Dr. Ruyi He, Former Chief Scientist, China Food and Drug Administration (CFDA)
    Kevin(Penghui) Chen, Founding Partner, Biotrack Capital
    Michael Kaufman, SVP, Mersana Therapeutics
    Jessica Li, Head of Asia Pacific Healthcare Investment Banking, Bank of America Merrill Lynch (BAML)
    Karen Liu, Founding Partner, 3E Bioventures Capital
  • 12:45 – 14:00
    AsymChem Lunch Reception
  • Session 2:
    Session 2: BFC Global Healthcare BD & Investment Forum
  • 14:00 – 15:00
    State of Healthcare Investment in China and US

    Moderator:Yumin (Benjamin) Qiu, Partner, Advantech
    Michael Xue, Managing Director, Morningside Ventures
    Armen B Shanafelt, General Partner, Lilly Ventures
    Xiaobo Lu, Partner, Sequoia Capital China
    Yining Zhao, Co-Founder & Executive Chairman, Transcenta Holding
  • 15:00 – 15:30
    Tea Break
  • 15:30 – 17:00
    Company Road Show    Roadshow Register  Roadshow Companies